Forbes September 29, 2024
David Phelan

When Apple revealed its latest Apple Watch models on Sept. 9, there was something missing, in the U.S. at least. The blood oxygen sensing feature which has been on the Apple Watch since Series 6 launched in 2020 (apart from Watch SE models) vanished almost a year ago because of a patent dispute with medical device maker Masimo. A new report claims it may return soon.

The longtime CEO of Masimo, Joe Kiani, has resigned from the company in the last few days and “that could open the door for lawyers from Apple and Masimo to work out a deal to bring blood-oxygen sensing back to new Apple Watches,” according to Bloomberg’s Mark Gurman in his latest Power On newsletter.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Technology, Wearables
ŌURA Snags $200M, Hits $5.2B Valuation
Adapting Cardiovascular Care with Emerging Tech Innovations
Wearable tech takes on heart health: Exploring advancements in cardiovascular disease monitoring
Wearable heart sound devices transform cardiovascular disease monitoring
Dexcom Adds Generative AI Platform to Its Over-the-Counter CGM

Share This Article